Answer
The most frequently reported adverse reactions to Tzield (teplizumab) in clinical studies were lymphopenia, leukopenia, neutropenia, decreased blood bicarbonate and rash, occurring more frequently than in controls.
Sources for this answer
- Tzield 2 mg/2 mL concentrate for solution for infusionSANOFI · emc · SmPC §4.8 Undesirable effects · Version 1Document updated
Sources checked